About this trial
Menstrual disorders, particularly dysmenorrhea (painful menstruation) and heavy menstrual bleeding (excessive menstrual blood loss), are common conditions among young adult females that can substantially impact quality of life, university attendance, and academic performance. This study aims to evaluate the prevalence of heavy menstrual bleeding and determine the intensity of dysmenorrhea among undergraduate female medical students at Assiut University.
Participants in this cross-sectional observational study include nulliparous and nulligravid female undergraduate students enrolled in the Faculty of Medicine. Data collection involves face-to-face interviews and self-completed assessment instruments during non-instructional hours. Dysmenorrhea severity, pain characteristics, and related functional impairment are evaluated using the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) score. Menstrual blood volume is quantified using the Pictorial Blood Loss Assessment Chart (PBLAC) during the menstrual period to identify heavy menstrual bleeding. Additionally, the study assesses associated physical symptoms, academic absenteeism, and common pharmacological and non-pharmacological management strategies utilized by the participants.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Undergraduate female students enrolled in the Faculty of Medicine, Assiut University
Nulliparous and nulligravid females
Disqualifiers
History of previous pregnancy or childbirth (currently gravid or parous females)
Students enrolled in non-medical faculties or postgraduate academic programs
Refusal or inability to complete the interview questionnaire or the Pictorial Blood Loss Assessment Chart (PBLAC)
Trial population
Undergraduate female medical students enrolled in the Faculty of Medicine at Assiut University, Assiut, Egypt. Eligible participants are nulliparous and nulligravid female students recruited on campus during non-learning hours to complete face-to-face interviews and menstrual symptom assessments.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Dysmenorrhea Severity Assessed by the WaLIDD Score
Assessed using the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) score. The instrument evaluates 4 domains: study/work ability (0 to 3), anatomical pain locations (0 to 3), pain intensity (0 to 3), and duration of pain in days (0 to 3). The total score ranges from 0 to 12 points, categorized as follows: 0 indicates no dysmenorrhea, 1 to 4 indicates mild dysmenorrhea, 5 to 7 indicates moderate dysmenorrhea, and 8 to 12 indicates severe dysmenorrhea. Higher scores reflect greater symptom severity and functional impairment.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: